Deutsche Bank Ag\ Vbi Vaccines Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.64 $34,067 - $75,184	-117,475 Reduced 41.98%	162,389 $48,000
Q4 2022 Feb 13, 2023	BUY	$0.38 - $22.5 $26,286 - $1.56 Million	69,175 Added 32.83%	279,864 $109,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $505 - $16,216	-693 Reduced 0.33%	210,689 $149,000
Q2 2022 Aug 11, 2022	BUY	$0.66 - $1.81 $17,804 - $48,826	26,976 Added 14.63%	211,382 $171,000
Q1 2022 May 13, 2022	BUY	$1.27 - $2.47 $62,795 - $122,129	49,445 Added 36.64%	184,406 $306,000
Q4 2021 Feb 11, 2022	BUY	$2.21 - $3.22 $9,257 - $13,488	4,189 Added 3.2%	134,961 $316,000
Q3 2021 Nov 04, 2021	SELL	$2.8 - $3.72 $14,232 - $18,908	-5,083 Reduced 3.74%	130,772 $407,000
Q2 2021 Aug 11, 2021	SELL	$2.61 - $4.17 $986 - $1,576	-378 Reduced 0.28%	135,855 $456,000
Q1 2021 May 13, 2021	SELL	$2.91 - $4.32 $31,879 - $47,325	-10,955 Reduced 7.44%	136,233 $423,000
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $115,457 - $187,953	53,701 Added 57.44%	147,188 $405,000
Q3 2020 Nov 12, 2020	BUY	$2.77 - $6.17 $23,054 - $51,352	8,323 Added 9.77%	93,487 $268,000
Q2 2020 Aug 13, 2020	BUY	$0.87 - $3.13 $26,827 - $96,516	30,836 Added 56.76%	85,164 $264,000
Q1 2020 May 14, 2020	SELL	$0.73 - $1.91 $2,000 - $5,235	-2,741 Reduced 4.8%	54,328 $52,000
Q4 2019 Feb 14, 2020	BUY	$0.48 - $1.38 $16,112 - $46,322	33,567 Added 142.83%	57,069 $77,000
Q3 2019 Nov 14, 2019	SELL	$0.47 - $1.05 $18,924 - $42,278	-40,265 Reduced 63.14%	23,502 $9,000
Q2 2019 Aug 14, 2019	BUY	$0.65 - $2.12 $41,448 - $135,186	63,767 New	63,767 $72,000
Q4 2018 Feb 14, 2019	SELL	$1.22 - $2.41 $78,324 - $154,722	-64,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.75 - $2.93 $65,310 - $109,347	37,320 Added 138.84%	64,200 $155,000
Q2 2018 Aug 14, 2018	SELL	$2.75 - $3.85 $58,682 - $82,155	-21,339 Reduced 44.25%	26,880 $73,000
Q1 2018 Oct 18, 2019	BUY	$3.5 - $4.47 $28,469 - $36,358	8,134 Added 20.29%	48,219 $168,000
Q1 2018 May 15, 2018	SELL	$3.5 - $4.47 $445,077 - $568,427	-127,165 Reduced 76.03%	40,085 $139,000
Q4 2017 Feb 14, 2018	BUY	$3.29 - $5.03 $486,623 - $743,987	147,910 Added 764.79%	167,250 $713,000
Q3 2017 Nov 14, 2017	BUY	$3.15 - $4.01 $60,921 - $77,553	19,340	19,340 $73,000

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio
ETF Managers Group, LLC Summit, NJ

85.7K
Shares

$1,714
0.0% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account